Rosa Giuliani

1.2k total citations
31 papers, 805 citations indexed

About

Rosa Giuliani is a scholar working on Oncology, Economics and Econometrics and Cancer Research. According to data from OpenAlex, Rosa Giuliani has authored 31 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Economics and Econometrics and 7 papers in Cancer Research. Recurrent topics in Rosa Giuliani's work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Rosa Giuliani is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (8 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Rosa Giuliani collaborates with scholars based in Italy, Netherlands and United Kingdom. Rosa Giuliani's co-authors include Solange Peters, Elisabeth G.E. de Vries, Martine Piccart, Malvika Vyas, Francesco Pignatti, Fátima Cardoso, Josep Tabernero, Marina Chiara Garassino, Ravindran Kanesvaran and Jonas Bergh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Rosa Giuliani

30 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosa Giuliani Italy	15	524	166	155	128	127	31	805
Timothée Olivier Switzerland	15	463 0.9×	123 0.7×	119 0.8×	341 2.7×	65 0.5×	83	873
Teresa Rodríguez Spain	19	546 1.0×	146 0.9×	119 0.8×	131 1.0×	253 2.0×	34	973
John D. Sprandio United States	15	371 0.7×	262 1.6×	236 1.5×	251 2.0×	107 0.8×	27	989
Lucien Perey Switzerland	18	444 0.8×	321 1.9×	117 0.8×	157 1.2×	128 1.0×	43	878
Eucario León-Rodrı́guez Mexico	13	284 0.5×	132 0.8×	85 0.5×	108 0.8×	95 0.7×	47	641
Meredith K. Chuk United States	14	429 0.8×	175 1.1×	116 0.7×	260 2.0×	133 1.0×	29	858
Mihaela Mates Canada	15	572 1.1×	99 0.6×	179 1.2×	188 1.5×	41 0.3×	50	837
Sudha Sundar United Kingdom	21	373 0.7×	243 1.5×	176 1.1×	134 1.0×	65 0.5×	103	1.5k
F J Cummings United States	20	691 1.3×	116 0.7×	300 1.9×	159 1.2×	245 1.9×	35	1.2k
Ann Setser United States	9	456 0.9×	167 1.0×	44 0.3×	250 2.0×	129 1.0×	11	1.0k

Countries citing papers authored by Rosa Giuliani

Since Specialization

Citations

This map shows the geographic impact of Rosa Giuliani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Giuliani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Giuliani more than expected).

Fields of papers citing papers by Rosa Giuliani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Giuliani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Giuliani. The network helps show where Rosa Giuliani may publish in the future.

Co-authorship network of co-authors of Rosa Giuliani

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Giuliani. A scholar is included among the top collaborators of Rosa Giuliani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Giuliani. Rosa Giuliani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jaeger, Ulrich, et al.. (2024). A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines Agency. Frontiers in Medicine. 11. 1399947–1399947. 2 indexed citations

Bayle, Arnaud, Julia Bonastre, Dan Chaltiel, et al.. (2023). ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe. Annals of Oncology. 34(10). 934–945. 51 indexed citations

Roitberg, Felipe, Teresa Amaral, Nathan I. Cherny, et al.. (2023). Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain. ESMO Open. 8(5). 101617–101617.

Perez‐Gracia, José Luis, Nicolas Penel, Emiliano Calvo, et al.. (2022). Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials. Annals of Oncology. 34(1). 70–77. 6 indexed citations

Zarkavelis, George, Ciska Verbaanderd, Nathan I. Cherny, et al.. (2022). Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines. ESMO Open. 8(1). 100604–100604. 9 indexed citations

Delgado, Julio, Camille Vleminckx, Jonas Bergh, et al.. (2021). The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer. ESMO Open. 6(2). 100074–100074. 12 indexed citations

Trapani, Dario, Shilpa S. Murthy, Mathieu Boniol, et al.. (2021). Distribution of the workforce involved in cancer care: a systematic review of the literature. ESMO Open. 6(6). 100292–100292. 28 indexed citations

Garassino, Marina Chiara, et al.. (2021). The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate. Annals of Oncology. 32(5). 579–581. 64 indexed citations

Giuliani, Rosa, et al.. (2019). Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology. ESMO Open. 4(2). e000460–e000460. 38 indexed citations

10.

Wolff‐Holz, Elena, Rosa Giuliani, Johan De Munter, et al.. (2018). Preparing for the incoming wave of biosimilars in oncology. ESMO Open. 3(6). e000420–e000420. 7 indexed citations

11.

Tabernero, Josep, Malvika Vyas, Rosa Giuliani, et al.. (2016). Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open. 1(6). e000142–e000142. 88 indexed citations

12.

Dias, Silvy da Rocha, Tomas Salmonson, Barbara van Zwieten‐Boot, et al.. (2013). The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use. European Journal of Cancer. 49(7). 1654–1661. 44 indexed citations

13.

Paola, Eugenio Donato Di, S. Alonso, Rosa Giuliani, et al.. (2012). An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors. SHILAP Revista de lepidopterología. 2. 175–175. 2 indexed citations

14.

Desmedt, Christine, Jeff Sperinde, Fanny Piette, et al.. (2009). Quantitation of HER2 Expression or HER2:HER2 Dimers and Differential Survival in a Cohort of Metastatic Breast Cancer Patients Carefully Selected for Trastuzumab Treatment Primarily by FISH. Diagnostic Molecular Pathology. 18(1). 22–29. 31 indexed citations

15.

Azambuja, Evandro de, Worta McCaskill‐Stevens, Prudence A. Francis, et al.. (2009). The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Research and Treatment. 119(1). 145–153. 128 indexed citations

16.

Calza, Leonardo, A. Zambruni, Marina Tadolini, et al.. (2005). Human herpesvirus‐8‐related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. Transplant Infectious Disease. 7(1). 34–37. 16 indexed citations

17.

Giuliani, Rosa, Marianne Paesmans, Jean-Yves Leroy, et al.. (2004). Is age a risk factor of congestive heart failure (CHF) in patients receiving trastuzumab (H)? Results from two Belgian compassionate use programs in metastatic breast cancer (MBC) patients (pts). Journal of Clinical Oncology. 22(14_suppl). 838–838. 4 indexed citations

18.

Leo, Angelo Di, Fátima Cardoso, Virginie Durbecq, et al.. (2002). Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002. International Journal of Clinical Oncology. 7(4). 245–253. 10 indexed citations

19.

Sobrero, Alberto, Alberto Zaniboni, Giovanni Luca Frassineti, et al.. (2000). Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study. Annals of Oncology. 11(11). 1413–1420. 15 indexed citations

20.

Moscetti, Luca, Rosa Saltarelli, Rosa Giuliani, et al.. (2000). Intra-Arterial Liver Chemotherapy and Hormone Therapy in Malignant Insulinoma: Case Report and Review of the Literature. Tumori Journal. 86(6). 475–479. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact